Effects of fumaric acid esters on blood–brain barrier tight junction proteins

K Bénardais, R Pul, V Singh, T Skripuletz, DH Lee… - Neuroscience …, 2013 - Elsevier
The blood–brain barrier (BBB) is composed of a network of tight junctions (TJ) which
interconnect cerebral endothelial cells (EC). Alterations in the TJ proteins are common in …

Dual action by fumaric acid esters synergistically reduces adhesion to human endothelium

J Breuer, S Herich… - Multiple Sclerosis …, 2018 - journals.sagepub.com
Objective: Dimethyl fumarate (DMF) is prescribed against relapsing-remitting multiple
sclerosis (MS). Here, we investigated the effects of DMF and monomethyl fumarate (MMF) …

[HTML][HTML] Fumaric acid esters do not reduce inflammatory NF-κB/p65 nuclear translocation, ICAM-1 expression and T-cell adhesiveness of human brain microvascular …

A Haarmann, M Nehen, A Deiß… - International Journal of …, 2015 - mdpi.com
Dimethyl fumarate (DMF) is approved for disease-modifying treatment of patients with
relapsing-remitting multiple sclerosis. Animal experiments suggested that part of its …

Protective effects of monomethyl fumarate at the inflamed blood–brain barrier

JL Lim, SMA van der Pol, F Di Dio, B van Het Hof… - Microvascular …, 2016 - Elsevier
Background Reactive oxygen species play a key role in the pathogenesis of multiple
sclerosis as they induce blood–brain barrier disruption and enhance transendothelial …

Dimethyl fumarate attenuates cerebral edema formation by protecting the blood–brain barrier integrity

R Kunze, A Urrutia, A Hoffmann, H Liu, X Helluy… - Experimental …, 2015 - Elsevier
Brain edema is a hallmark of various neuropathologies, but the underlying mechanisms are
poorly understood. We aim to characterize how tissue hypoxia, together with oxidative stress …

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

RA Linker, DH Lee, S Ryan, AM van Dam, R Conrad… - Brain, 2011 - academic.oup.com
Inflammation and oxidative stress are thought to promote tissue damage in multiple
sclerosis. Thus, novel therapeutics enhancing cellular resistance to free radicals could prove …

[HTML][HTML] Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters

DH Lee, R Gold, RA Linker - International journal of molecular sciences, 2012 - mdpi.com
Oxidative stress plays a crucial role in many neurodegenerative conditions such as
Alzheimer's disease, amyotrophic lateral sclerosis and Parkinson's as well as Huntington's …

Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway

J Lin-Holderer, L Li, D Gruneberg, HH Marti… - Neuropharmacology, 2016 - Elsevier
Oxidative stress is a hallmark of ischemic stroke pathogenesis causing neuronal malfunction
and cell death. Up-regulation of anti-oxidative genes through activation of the NF-E2-related …

Tight junctions in brain barriers during central nervous system inflammation

C Coisne, B Engelhardt - Antioxidants & redox signaling, 2011 - liebertpub.com
Homeostasis within the central nervous system (CNS) is a prerequisite to elicit proper
neuronal function. The CNS is tightly sealed from the changeable milieu of the blood stream …

[HTML][HTML] Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain …

H Wilms, J Sievers, U Rickert, M Rostami-Yazdi… - Journal of …, 2010 - Springer
Background Brain inflammation plays a central role in multiple sclerosis (MS).
Dimethylfumarate (DMF), the main ingredient of an oral formulation of fumaric acid esters …